Holen Sie sich die Stockscreener-App
9.625
0.68%
0.065
Finanzdaten der Atara Biotherapeutics Inc-Aktie (ATRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
22.09%
0.63
|
0.516 | 1.595 | 3.453 | 17.57 |
| Research and Development |
720.12%
1.345
|
0.164 | -0.223 | - | - |
| Interest Income/Expense |
76.99%
0.191
|
0.83 | 0.894 | 0.909 | 0.972 |
| Costs And Expenses |
37.71%
5.35
|
3.885 | 4.158 | 7.027 | 14.38 |
| Depreciation and Amortization |
51.72%
0.014
|
0.029 | 0.049 | 0.036 | 0.236 |
| Operating Income/Loss |
40.10%
-4.72
|
-3.369 | -2.563 | -3.574 | 3.197 |
| Income/Loss From Continuing Operations Before Tax |
16.60%
-4.833
|
-4.145 | -3.406 | -4.275 | 2.39 |
| Income Tax Expense/Benefit |
0.001
|
- | - | 0.028 | 0.003 |
| Net Income/Loss |
16.62%
-4.834
|
-4.145 | -3.406 | -4.303 | 2.387 |
| Basic Average Shares |
6.76%
15.03
|
14.08 | - | 13.56 | 12.20 |
| Diluted Average Shares |
6.76%
15.03
|
14.08 | - | 13.56 | 12.31 |
| Basic Earnings Per Share |
10.34%
-0.32
|
-0.29 | - | -0.32 | 0.20 |
| Diluted Earnings Per Share |
10.34%
-0.32
|
-0.29 | - | -0.32 | 0.19 |
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):